SMPDL3B Predicts Poor Prognosis and Contributes to Development of Acute Myeloid Leukemia
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Molecular Biosciences"
DOI: 10.3389/fmolb.2021.695601
Abstract: Background: Acute myeloid leukemia (AML), characterized by the low cure rate and high relapse, urgently needs novel diagnostic or prognostic biomarkers and potential therapeutic targets. Sphingomyelin Phosphodiesterase Acid Like 3B (SMPDL3B) is a negative regulator… read more here.
Keywords: smpdl3b; myeloid leukemia; expression; acute myeloid ... See more keywords